Dr. Dalovisio is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1514 Jefferson Hwy
New Orleans, LA 70121Phone+1 504-842-3910
Education & Training
Rush University Medical CenterFellowship, Hematology and Medical Oncology, 2012 - 2015- Rush University Medical CenterResidency, Internal Medicine, 2009 - 2012
LSU School of Medicine in ShreveportClass of 2009
Certifications & Licensure
LA State Medical License 2015 - 2025
AL State Medical License 2020 - 2020
IL State Medical License 2012 - 2017
Publications & Presentations
PubMed
- 32 citationsElranatamab in relapsed or refractory multiple myeloma: the MagnetisMM-1 phase 1 trial.Nizar J Bahlis, Caitlin L Costello, Noopur S Raje, Moshe Y Levy, Bhagirathbhai Dholaria
Nature Medicine. 2023-10-01 - 27 citationsOlder Patients With Acute Myeloid Leukemia: Treatment Challenges and Future Directions.Laura Finn, Andrew P. Dalovisio, James M. Foran
Ochsner Journal. 2017-12-01 - 10 citationsUpdated safety of midostaurin plus chemotherapy in newly diagnosed FLT3 mutation-positive acute myeloid leukemia: the RADIUS-X expanded access program.Gail J. Roboz, Stephen A. Strickland, Mark R. Litzow, Andrew Dalovisio, Alexander E. Perl
Leukemia & Lymphoma. 2020-08-19
Press Mentions
Ochsner Health Expert Available to Comment on Multiple MyelomaSeptember 1st, 2022
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
